Allianz Asset Management Gmb H Inovio Pharmaceuticals, Inc. Transaction History

Allianz Asset Management Gmb H

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$8.5 - $12.85 $425,884 - $643,836	-50,104 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$9.57 - $27.05 $46,816 - $132,328	-4,892 Reduced 8.9%	50,104 $582,000
Q2 2020 Aug 14, 2020	BUY	$7.14 - $31.69 $392,671 - $1.74 Million	54,996 New	54,996 $1.48 Million
Q3 2018 Nov 13, 2018	SELL	$3.92 - $5.58 $842,643 - $1.2 Million	-214,960 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$3.88 - $5.16 $4,822 - $6,413	-1,243 Reduced 0.57%	214,960 $843,000
Q1 2018 May 14, 2018	SELL	$4.05 - $5.69 $14,818 - $20,819	-3,659 Reduced 1.66%	216,203 $1.02 Million
Q4 2017 Feb 13, 2018	SELL	$4.13 - $6.68 $12,001 - $19,412	-2,906 Reduced 1.3%	219,862 $908,000
Q3 2017 Nov 13, 2017	BUY	$5.36 - $6.37 $132,134 - $157,033	24,652 Added 12.44%	222,768 $1.41 Million
Q2 2017 Aug 14, 2017	BUY	N/A	11,217 Added 6.0%	198,116 $1.55 Million
Q1 2017 Apr 17, 2019	BUY	N/A	52,304 Added 38.86%	186,899 $1.24 Million
Q4 2016 Apr 17, 2019	SELL	N/A	-17,586 Reduced 11.56%	134,595 $934,000
Q3 2016 Apr 17, 2019	BUY	N/A	152,181	152,181 $1.42 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $990M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.